Changes in porphyrin metabolism in overweight diabetic patients
Pisanetz, M.; Pavlov, K.
Folia Medica 24(2): 35-39
1982
ISSN/ISBN: 0204-8043 PMID: 6815030 Document Number: 184133
Document emailed within 1 workday
Related Documents
Sarinnapakorn, V.; Wanicagool, W. 2013: Association between hs-CRP and Hba1c in overweight type 2 diabetic female patients Journal of the Medical Association of Thailand 96 Suppl. 3: S54-S58Kaizu, Y.; Tsunega, Y.; Yoneyama, T.; Sakao, T.; Hibi, I.; Miyaji, K.; Kumagai, H. 1998: Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients Clinical Nephrology 50(1): 44-50
Andréka, P.; Fehér, J. 1993: Alcoholic liver damage and impaired porphyrin metabolism Orvosi Hetilap 134(25): 1347-1352
Eales, L.; Thatcher, G.N.; Grosser, Y.; Levey, M. 1970: Renal function and porphyrin metabolism following cardiac transplantation South African Medical Journal 44(11): 322-328
Goerz, G.; Bolsen, K.; Vardarman, E.; Rominger, K.L. 1993: Influence of clonidine on the porphyrin metabolism in female rats Arzneimittel-Forschung 43(12): 1309-1312
Fiedler, H. 1971: Modification of porphyrin metabolism by griseofulvin. I. Biochemical bases Dermatologische Monatschrift 157(2): 79-87
Curnow, A.; Pye, A. 2007: Biochemical manipulation via iron chelation to enhance porphyrin production from porphyrin precursors Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 26(2): 89-103
Rocchi, E.; Casalgrandi, G.; Masini, A.; Giovannini, F.; Ceccarelli, D.; Ferrali, M.; Marchini, S.; Ventura, E. 1999: Circulating pro- and antioxidant factors in iron and porphyrin metabolism disorders Italian Journal of Gastroenterology and Hepatology 31(9): 861-867
Schermuly, E.; Doss, M. 1976: Porphyrin biosynthesis from ALA and PBG by human erythrocytes in porphyrin disorders. Kinetic studies of the isomer series i and IIi Annals of Clinical Research 8(Suppl 17): 92-102
Shliapnikova, E.A.; Savitskiĭ, A.P.; Kachalova, G.S. 1986: Accessibility of porphyrin macrocycle in myoglobin at various pH levels. Fluorescence study of the porphyrin-globin complex Molekuliarnaia Biologiia 20(1): 138-145
Panfilova, I.K. 1971: Some aspects of porphyrin metabolism in children with anemia in respiratory viral infections Voprosy Okhrany Materinstva i Detstva 16(3): 80-81
Dobrotina, N.A.; Krivosheev, B.N. 1974: Content and functional activity of serum proteins and certain problems of pathogenesis of dermatoses with disorders of porphyrin metabolism Vestnik Dermatologii i Venerologii 48(3): 42-48
Woods, J.S.; Eaton, D.L.; Lukens, C.B. 1984: Studies on porphyrin metabolism in the kidney. Effects of trace metals and glutathione on renal uroporphyrinogen decarboxylase Molecular Pharmacology 26(2): 336-341
Herrick, A.; McColl, K.E.; McLellan, A.; Moore, M.R.; Brodie, M.J.; Goldberg, A. 1987: Effect of haem arginate therapy on porphyrin metabolism and mixed function oxygenase activity in acute hepatic porphyria Lancet 2(8569): 1178-1179
Balog, P.; Dvorzhak, E. 1972: Effect of drugs on nitrogen metabolism in diabetic patients Problemy Endokrinologii 18(4): 34-37
Krivosheev, A.B.; Maximov, V.N.; Voevoda, M.I.; Kuimov, A.D.; Kondratova, M.A.; Tuguleva, T.A.; Koval, O.N.; Bezrukova, A.A.; Bogorianova, P.A.; Rybina, O.V. 2015: Alleles C282y and H63d Hfe Gene, Insulin Resistance and Susceptibility to Disturbance of Porphyrin Metabolism in Non-Alcoholic Fatty Liver Disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 3: 39-44
Mikhailova, E.V. 1973: Change in the lipid metabolism indices during the treatment of patients with diabetic obesity Problemy Endokrinologii 19(3): 8-11
Miranda, C.L.; Wang, J.L.; Henderson, M.C.; Nakaue, H.S.; Buhler, D.R. 1984: Effects of chlorobenzenes on hepatic porphyrin and drug metabolism in chick embryo and day-old chick Research Communications in Chemical Pathology and Pharmacology 46(1): 13-24
Lohmann, D.; Liebold, F.; Heilman, W. 1975: Secretion of insulin and disorders in fatty acid metabolism in diabetic patients with coronary heart diseases Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 30(12): 84-86
Fehmann, H.C. 2001: Alpha-glucosidase inhibitor in type 2 diabetic patients. Metabolism and body weight are favorably modified MMW Fortschritte der Medizin 143(17): 46